Home LiteratureArticle Details
PMID: 10878068 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea.

Journal of clinical microbiology ·Vol. 38 ·No. 7 ·2000-07-00 ·Pages 2706-14

Alfa MJ, Kabani A, Lyerly D, Moncrief S, Neville LM, Al-Barrak A, Harding GK, Dyck B, Olekson K, Embil JM

Abstract

Clostridium difficile-associated diarrhea (CAD) is a very common nosocomial infection that contributes significantly to patient morbidity and mortality as well as to the cost of hospitalization. Previously, strains of toxin A-negative, toxin B-positive C. difficile were not thought to be associated with clinically significant disease. This study reports the characterization of a toxin A-negative, toxin B-positive strain of C. difficile that was responsible for a recently described nosocomial outbreak of CAD. Analysis of the seven patient isolates from the outbreak by pulsed-field gel electrophoresis indicated that this outbreak was due to transmission of a single strain of C. difficile. Our characterization of this strain (HSC98) has demonstrated that the toxin A gene lacks 1.8 kb from the carboxy repetitive oligopeptide (CROP) region but apparently has no other major deletions from other regions of the toxin A or toxin B gene. The remaining 1.3-kb fragment of the toxin A CROP region from strain HSC98 showed 98% sequence homology with strain 1470, previously reported by M. Weidmann in 1997 (GenBank accession number Y12616), suggesting that HSC98 is toxinotype VIII. The HSC98 strain infecting patients involved in this outbreak produced the full spectrum of clinical illness usually associated with C. difficile-associated disease. This pathogenic spectrum was manifest despite the inability of this strain to alter tight junctions as determined by using in vitro tissue culture testing, which suggested that no functional toxin A was produced by this strain.

MeSH Terms
Adolescent Adult Aged Bacterial Proteins Bacterial Toxins/genetics,metabolism Caco-2 Cells Child, Preschool Clostridioides difficile/classification,genetics,isolation & purification,pathogenicity Clostridium Infections/epidemiology,microbiology Cross Infection/epidemiology,microbiology Diarrhea/epidemiology,microbiology Disease Outbreaks Electrophoresis, Gel, Pulsed-Field Enterotoxins/genetics,metabolism Feces/microbiology Female Humans Male Middle Aged Sequence Analysis, DNA
Chemicals
Bacterial Proteins Bacterial Toxins Enterotoxins tcdA protein, Clostridium difficile toxB protein, Clostridium difficile
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Alfa M J
Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada. malfa@cc.umanitoba.ca
Kabani A
Lyerly D
Moncrief S
Neville L M
Al-Barrak A
Harding G K
Dyck B
Olekson K
Embil J M
References (36)
36 references, click to expand
  1. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers.
    Gastroenterology. 1992 Feb;102(2):416-23 PMID: 1732112
  2. Clostridium difficile toxin A and its effects on cells.
    Toxicon. 1991;29(6):543-67 PMID: 1926159
  3. Separate isolation of Clostridium difficile spores and vegetative cells from the feces of newborn infants.
    Microbiol Immunol. 1992;36(2):131-8 PMID: 1584078
  4. Comparative sequence analysis of the Clostridium difficile toxins A and B.
    Mol Gen Genet. 1992 May;233(1-2):260-8 PMID: 1603068
  5. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection.
    J Infect Dis. 1992 Sep;166(3):561-7 PMID: 1323621
  6. Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.
    Infect Immun. 1992 Oct;60(10):4192-9 PMID: 1398930
  7. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.
    Infect Immun. 1992 Nov;60(11):4633-9 PMID: 1398977
  8. Demonstration of toxin A and B by polymerase chain reaction and McCoy cell assay in clinical isolates of Clostridium difficile from Denmark.
    APMIS. 1993 Jan;101(1):18-22 PMID: 8457321
  9. Clostridium difficile: a pathogen of the nineties.
    Eur J Clin Microbiol Infect Dis. 1998 Mar;17(3):137-41 PMID: 9665293
  10. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR.
    J Clin Microbiol. 1998 Aug;36(8):2178-82 PMID: 9665986
  11. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates.
    J Clin Microbiol. 1998 Aug;36(8):2240-7 PMID: 9665999
  12. Increasing hospitalization and death possibly due to Clostridium difficile diarrheal disease.
    Emerg Infect Dis. 1998 Oct-Dec;4(4):619-25 PMID: 9866738
  13. An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital.
    Can Commun Dis Rep. 1999 Apr 1;25(7):65-9 PMID: 10344088
  14. Purification and characterization of toxins A and B of Clostridium difficile.
    Infect Immun. 1982 Mar;35(3):1032-40 PMID: 7068210
  15. Effects of Clostridium difficile toxins given intragastrically to animals.
    Infect Immun. 1985 Feb;47(2):349-52 PMID: 3917975
  16. Biological mode of action of Clostridium difficile toxin A: a novel enterotoxin.
    J Med Microbiol. 1987 May;23(3):211-9 PMID: 3585958
  17. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers.
    J Clin Invest. 1988 Nov;82(5):1516-24 PMID: 3141478
  18. Clostridium difficile: its disease and toxins.
    Clin Microbiol Rev. 1988 Jan;1(1):1-18 PMID: 3144429
  19. Molecular characterization of the Clostridium difficile toxin A gene.
    Infect Immun. 1990 Feb;58(2):480-8 PMID: 2105276
  20. Clostridium difficile: clinical considerations.
    Rev Infect Dis. 1990 Jan-Feb;12 Suppl 2:S243-51 PMID: 2406876
  21. Identification of toxigenic Clostridium difficile strains by using a toxin A gene-specific probe.
    J Clin Microbiol. 1990 Aug;28(8):1808-12 PMID: 2118549
  22. Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A.
    J Med Microbiol. 1991 Jul;35(1):40-4 PMID: 1906544
  23. Identification and characterization of adhesive factors of Clostridium difficile involved in adhesion to human colonic enterocyte-like Caco-2 and mucus-secreting HT29 cells in culture.
    Mol Microbiol. 1993 Feb;7(3):371-81 PMID: 8459765
  24. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.
    J Med Microbiol. 1993 Jun;38(6):434-41 PMID: 8510136
  25. Application of typing by pulsed-field gel electrophoresis to the study of Clostridium difficile in a neonatal intensive care unit.
    J Clin Microbiol. 1994 Sep;32(9):2067-70 PMID: 7814526
  26. Clostridium difficile-associated diarrhea and colitis.
    Infect Control Hosp Epidemiol. 1995 Aug;16(8):459-77 PMID: 7594392
  27. Clostridial disease of the gut.
    Clin Infect Dis. 1995 Jun;20 Suppl 2:S242-50 PMID: 7548565
  28. Closing in on the toxic domain through analysis of a variant Clostridium difficile cytotoxin B.
    Mol Microbiol. 1995 Jul;17(2):313-21 PMID: 7494480
  29. Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTP-binding proteins.
    Trends Microbiol. 1996 Oct;4(10):375-82 PMID: 8899962
  30. Surgical aspects of Clostridium difficile colitis.
    Br J Surg. 1997 Feb;84(2):150-9 PMID: 9052424
  31. Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile.
    FEMS Microbiol Lett. 1997 Mar 15;148(2):197-202 PMID: 9084148
  32. Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control.
    Infect Control Hosp Epidemiol. 1997 Sep;18(9):628-32 PMID: 9309434
  33. Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection.
    Infect Immun. 1998 May;66(5):2018-25 PMID: 9573084
  34. Clostridium difficile--associated diarrhea.
    Clin Infect Dis. 1998 May;26(5):1027-34; quiz 1035-6 PMID: 9597221
  35. Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches.
    J Clin Microbiol. 1998 Jul;36(7):2076-80 PMID: 9650966
  36. Nontoxigenic strains of Clostridium difficile lack the genes for both toxin A and toxin B.
    J Clin Microbiol. 1991 Nov;29(11):2666-7 PMID: 1774285
Article Info
Journal
Journal of clinical microbiology
Abbr.
J Clin Microbiol
ISSN
0095-1137
Published
2000-07-00
Pages
2706-14
Language
English
Region
United States
NLM ID
7505564
PMCID
PMC87004
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com